Listen

Description

Until recently, it was thought a normal cycle for women was 28 days. While data now shows this is not the case, innovative tools continue to be developed to better understand what is "normal" for a given woman. Dr Amy Divaraniya, the CEO and co-founder of OOVA speaks with Fempower Health.In this episode, Amy covers:


Resources

If you're passionate about advancing women's health, there are many ways you can support the Fempower Health Podcast. Here's how:
  1. Subscribe and Listen: Tune in to new episodes every Tuesday by subscribing to the Fempower Health Podcast on iTunes or Spotify or your favorite podcast platform. Your regular listenership is invaluable!
  2. Leave a Review: Help us grow by leaving a review on iTunes or Spotify. Your feedback not only supports us but also helps others discover our podcast.
  3. Share with Others: Spread the word by sharing episodes with friends, family, or anyone interested in women's health. Every share helps!
  4. Engage with Our Community: Follow us on Instagram, Facebook, and Twitter for the latest updates and engaging content.
  5. Stay Informed: Sign up for our weekly newsletter to receive the latest announcements, news, and research directly in your inbox.
  6. Reach Out: We love hearing from you! Reach out for inquiries, outreach, or even to share your questions and topics of interest.

Together, let's build a stronger community dedicated to women's health. Your support is crucial in this journey!
More About Dr Amy DivaraniyaDr. Amy Divaraniya is the CEO and Co-Founder of OOVA, a women’s health company. She has more than 10 years of experience as a data scientist and has both led and published original research in the areas of personal genomics and biomarker discovery. In 2017, Dr. Divaraniya chose to pivot her career as a data scientist and devote herself to improving women’s healthcare. After facing her own struggles with conceiving her son, Dr. Divaraniya decided to build a solution to help women having difficulty getting pregnant. Today, her and her team have built the first at home test, OOVA, that measures multiple hormones through urine samples and provides personalized results and insights on a woman’s fertility. As a response to COVID-19, OOVA has done an early product release, which has resonated with many women and clinicians and is now being adopted by fertility clinics and hospitals across the country.
**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor.  Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**
**Contains affiliate links and I will be compensated if you make a purchase after clicking on my links**